Market Movers (8-K)
See all →Chiron Real Estate Inc. amends its prior filing to provide comprehensive financial details on its recent acquisitions of The Landing Alexandria and The Riviera Alexandria, totaling $248.9 million.
Chiron Real Estate Inc. announced its second quarter 2026 financial results, detailing progress in portfolio repositioning through SHOP acquisitions and legacy asset sales, alongside leadership team expansions.
Capital raise
Worse than expected
Chiron Real Estate Inc. announced the appointment of Matthew Whitlock as Chief Investment Officer and the transition of Alfonzo Leon to Strategic Advisor, effective August 3, 2026.
Chiron Real Estate Inc. has announced key executive appointments and entered into new employment agreements with its senior leadership team, effective July 16, 2026.
Chiron Real Estate Inc. has updated its investor presentation, detailing strategic portfolio repositioning, capital allocation, and recent transactions aimed at delivering higher returns on invested capital.
Chiron Real Estate Inc. has completed the sale of a seven-property inpatient rehabilitation hospital portfolio for $217 million, retaining a 15% interest in the acquiring joint venture.
Quarterly Earnings (10-Q)
See all →Chiron Real Estate Inc. reported strong Q2 2026 results, driven by strategic acquisitions of seniors housing communities and a significant gain from the sale of investment properties.
Capital raise
Better than expected
Chiron Real Estate Inc. reported a net income decrease for Q1 2026 compared to Q1 2025, alongside significant strategic acquisitions and a dividend modification.
Worse than expected
Capital raise
Global Medical REIT Inc. reported a net loss for Q3 2025, driven by an impairment charge and increased interest expenses, while successfully extending significant debt maturities post-quarter.
Capital raise
Worse than expected
Global Medical REIT Inc. reported increased net income for Q2 2025, driven by acquisitions, but reduced its common stock dividend to strengthen its balance sheet.
Worse than expected
Capital raise
10-Q: Global Medical REIT Reports Q1 2025 Results, Navigating Interest Rate and Healthcare Wage Inflation
Global Medical REIT's Q1 2025 results show a slight decrease in revenue offset by gains on property sales, while the company addresses challenges from interest rate hikes and healthcare wage inflation.
Global Medical REIT's third-quarter results show a decrease in revenue and net income compared to the previous year, influenced by property dispositions and acquisitions.
Worse than expected
Capital raise
Annual Reports (10-K)
Chiron Real Estate Inc. reported a net loss of $6.9 million for the fiscal year ended December 31, 2025, driven by significant property impairment charges and increased interest expenses, despite higher rental revenue.
Worse than expected
Capital raise
Global Medical REIT's 2024 results reflect a complex environment with strategic dispositions, acquisitions, and leadership changes impacting financial performance.
Worse than expected
Global Medical REIT Inc. released its 2023 annual report, detailing financial performance, strategic initiatives, and risk factors.
Worse than expected
Capital raise
Insider Trading (Form 4)
See all →Matthew Fitzsimmons Whitlock, Chief Investment Officer of Global Medical REIT Inc., purchased 1,000 shares of common stock on August 14, 2026.
Mark Okey Decker Jr, CEO and President and a Director of Global Medical REIT Inc., purchased 6,875 shares of common stock on August 11, 2026 for $35.92 per share.
Aaron Robert Roseth, COO and a Director of Global Medical REIT Inc., purchased 13,500 shares of common stock on August 12, 2026 for $36.73 per share.
Mark Okey Decker Jr, CEO and President and a Director of Global Medical REIT Inc., purchased 550 shares of common stock on August 11, 2026 for $36.00 per share.
Charles Fitzgerald, a Director of Global Medical REIT Inc., purchased 14,000 shares of common stock on August 11, 2026 for $35.78 per share.
Mark Okey Decker Jr, CEO and President and a Director of Global Medical REIT Inc., purchased 8,000 shares of common stock on August 10, 2026 for $35.88 per share.
Proxy Statements (Def-14A)
Chiron Real Estate Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on May 20, 2026, with key proposals including director elections and equity plan amendments.
Global Medical REIT Inc. has filed a definitive proxy statement with the SEC.
Global Medical REIT will hold its annual stockholder meeting virtually on May 14, 2025, to elect directors, approve executive compensation, and ratify the appointment of Deloitte & Touche LLP as its independent accounting firm.
Worse than expected
Global Medical REIT Inc. will hold its annual meeting of stockholders virtually on May 15, 2024, to vote on director elections, executive compensation, an equity incentive plan amendment, and auditor ratification.
Global Medical REIT's annual stockholder meeting will be held virtually on May 15, 2024, to vote on director elections, executive compensation, and other corporate matters.
Schedule 13G - Passive Investments
Vanguard Portfolio Management has reported beneficial ownership of 666,452 shares, representing 5.03% of Chiron Real Estate Inc.'s common stock.
The Vanguard Group has reported a complete divestment of its beneficial ownership in Chiron Real Estate Inc. due to an internal corporate realignment.
Prudential Financial, Inc. has filed an amendment to its beneficial ownership report, disclosing a 2.2% stake in Global Medical REIT Inc.
Prudential Financial Inc. has disclosed a 5.1% beneficial ownership stake in Global Medical REIT Inc. as of March 31, 2025, through a Schedule 13G filing.